Baldrige Asset Management »

Vir Biotechnology shares owned by Baldrige Asset Management

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Baldrige Asset Management from 13F filings

Historical chart of Baldrige Asset Management investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Baldrige Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Baldrige Asset Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $0 13 0.00

More positions owned by Baldrige Asset Management

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Msci (MSCI)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust World Ex Us Core (DFAX)
Vanguard Index Fds Real Estate Etf (VNQ)
Ishares Tr Core S&p Ttl Stk (ITOT)
Schwab Strategic Tr 1 5yr Corp Bd (SCHJ)
Air Products & Chemicals (APD)

View all positions for Baldrige Asset Management

Top funds holding Vir Biotechnology

Sb Investment Advisers
BlackRock
Vanguard Group
State Street Corporation
OrbiMed Advisors
Geode Capital Management
Leucadia National Corporation
Bill & Melinda Gates Foundation
Dimensional Fund Advisors
Renaissance Technologies
Charles Schwab Investment Management
Millennium Management
Jpmorgan Chase & Co
Voloridge Investment Management
D. E. Shaw & Co

View all funds holding Vir Biotechnology